Back to Search Start Over

Maximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed. Part 12: Tetracyclines: tetracycline, chlortetracycline, oxytetracycline, and doxycycline

Authors :
EFSA Panel on Biological Hazards (BIOHAZ)
Konstantinos Koutsoumanis
Ana Allende
Avelino Alvarez‐Ordóñez
Declan Bolton
Sara Bover‐Cid
Marianne Chemaly
Robert Davies
Alessandra De Cesare
Lieve Herman
Friederike Hilbert
Roland Lindqvist
Maarten Nauta
Giuseppe Ru
Marion Simmons
Panagiotis Skandamis
Elisabetta Suffredini
Dan I Andersson
Vasileios Bampidis
Johan Bengtsson‐Palme
Damien Bouchard
Aude Ferran
Maryline Kouba
Secundino López Puente
Marta López‐Alonso
Søren Saxmose Nielsen
Alena Pechová
Mariana Petkova
Sebastien Girault
Alessandro Broglia
Beatriz Guerra
Matteo Lorenzo Innocenti
Ernesto Liébana
Gloria López‐Gálvez
Paola Manini
Pietro Stella
Luisa Peixe
Source :
EFSA Journal, Vol 19, Iss 10, Pp n/a-n/a (2021)
Publication Year :
2021
Publisher :
Wiley, 2021.

Abstract

Abstract The specific concentrations of tetracycline, chlortetracycline, oxytetracycline and doxycycline in non‐target feed for food‐producing animals, below which there would not be an effect on the emergence of, and/or selection for, resistance in bacteria relevant for human and animal health, as well as the specific antimicrobial concentrations in feed which have an effect in terms of growth promotion/increased yield were assessed by EFSA in collaboration with EMA. Details of the methodology used for this assessment, associated data gaps and uncertainties are presented in a separate document. To address antimicrobial resistance, the Feed Antimicrobial Resistance Selection Concentration (FARSC) model developed specifically for the assessment was applied. The FARSC for these four tetracyclines was estimated. To address growth promotion, data from scientific publications obtained from an extensive literature review were used. Levels in feed that showed to have an effect on growth promotion/increased yield were reported for tetracycline, chlortetracycline, oxytetracycline, whilst for doxycycline no suitable data for the assessment were available. Uncertainties and data gaps associated with the levels reported were addressed. It was recommended to perform further studies to supply more diverse and complete data related to the requirements for calculation of the FARSC for these antimicrobials.

Details

Language :
English
ISSN :
18314732
Volume :
19
Issue :
10
Database :
Directory of Open Access Journals
Journal :
EFSA Journal
Publication Type :
Academic Journal
Accession number :
edsdoj.29409418813a439399222df6616935f6
Document Type :
article
Full Text :
https://doi.org/10.2903/j.efsa.2021.6864